Effect of FIXed-dose combination of ARb and statin on adherence and risk factor control: The randomized FIXAR study.

Seyong ChungYoung-Guk KoJung Sun KimByeong-Keuk KimChul-Min AhnSungha ParkSung-Jin HongSang-Hak LeeDonghoon Choi

Published in: Cardiology journal (2020)

Patients' adherence was excellent and similar in the groups, whereas the reduction in the LDL-C level was greater in the FDC group. We provide comprehensive information on the adherence and efficacy of an FDC compared to the usual regimen in Korean patients with high cardiovascular risk.

Keyphrases

end stage renal disease
newly diagnosed
chronic kidney disease
risk factors
cardiovascular disease
double blind
prognostic factors
coronary artery disease
open label
glycemic control
randomized controlled trial
placebo controlled
clinical trial
type diabetes
metabolic syndrome
insulin resistance
health information